Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA

LONDON, Ontario and WINDHAM COUNTY, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. SVA SEOVF (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) and Rare…#ontario #windhamcounty #conn #sernovacorp #psh #fda #hemophilia #hemophiliaa #cellpouch #factorviii
Source: Reuters: Health - Category: Consumer Health News Source Type: news